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Overcoming the cellular type I interferon (IFN) host
defense response is critical for a virus to ensure
successful infection. Investigating the effects of
human adenovirus (HAdV) infection on global cellular
histone posttranslational modification (hPTM), we
discovered that virus infection-induced activation
of IFN signaling triggers a global increase in the
monoubiquitination of histone 2B (H2B) at lysine
120, which is a mark for transcriptionally active chro-
matin. This hPTM, catalyzed by the hBre1/RNF20
complex, is necessary for activation of the cellular
IFN-stimulated gene (ISG) expression program in
response to viruses. To establish effective infection,
the HAdV E1A protein binds to and dissociates
the hBre1 complex to block IFN-induced H2B mono-
ubiquitination and associated ISG expression. To-
gether, these data uncover a key role for H2B
monoubiquitination in the type I IFN response and
a viral mechanism of antagonizing this hPTM to
evade the IFN response.
INTRODUCTION
Eukaryotic DNA is compacted via association with protein to
form a highly organized polymer called chromatin (Campos
and Reinberg, 2009). The fundamental subunit of chromatin is
the nucleosome, which is formed by wrapping DNA around an
octamer of histone proteins. hPTMs actively alter chromatin
structure in a dynamic and often reversible process (Campos
and Reinberg, 2009; Li et al., 2008; Rice et al., 2003). These
enzyme-mediated covalent histone modifications affect the
compaction of cellular chromatin and are vital for any process
requiring access to the DNA template (Braunstein et al., 1993;
Rice et al., 2003; Sullivan and Karpen, 2004). In particular,
many of these modifications directly or indirectly influence theCell Hrecruitment of transcriptional regulatory factors to chromatin,
providing an additional mechanism to control gene expression
(Campos and Reinberg, 2009; Garske et al., 2010; Li et al.,
2008; Wysocka, 2006). Mounting evidence suggests that global
changes in histone modifications lead to global changes in gene
expression during disease processes including cancer and
infection (Chi et al., 2010; Ferrari et al., 2009; Lilley et al., 2010).
Viruses are obligate intracellular pathogens. As such, they
have evolved simple yet elegant mechanisms to reprogram
cellular systems for the benefit of the virus. Not surprisingly,
many viruses target and utilize hPTMs to modify cellular and
viral transcription and optimize the cellular environment for virus
replication. Human adenovirus (HAdV) is a small DNA tumor virus
that is able to transform cells and cause malignancies in rodents
(Pelka et al., 2008). As an infectious human pathogen, HAdV only
has access to the terminally differentiated cells of the exposed
epithelial surfaces such as in the respiratory and gastrointestinal
tracts. These quiescent cells do not provide an ideal environment
for virus replication. To overcome this difficulty, the E1A proteins
of HAdV have evolved to reprogram this suboptimal cellular envi-
ronment into one more conducive to virus replication. E1A is the
first viral gene expressed during infection, and it plays critical
roles in modulating transcription, forcing infected quiescent cells
back into the cell cycle and suppressing cellular innate antiviral
responses. The interaction between the viral E1A protein and
several enzymes comprising the cellular hPTM apparatus,
particularly the p300/CBP acetyltransferases, is well estab-
lished, and E1A exploits these interactions to alter gene expres-
sion and cell growth (Pelka et al., 2008). Indeed, recent work has
established that E1A globally reprograms histone 3 lysine 18
(H3-K18) acetylation in order to coerce quiescent cells to repli-
cate in a process akin to that observed in some cancers (Horwitz
et al., 2008).
hBre1/RNF20 is a member of a complex involved in the mono-
ubiquitination of H2B at lysine 120 (H2B-ub), and we detected it
as an interacting partner of E1A in a yeast two-hybrid screen.
In this study, we have focused on characterizing the effect of
E1A on global H2B-ub. In eukaryotes, H2B-ub marks chro-
matin that is highly transcriptionally active and is involved in effi-
cient transcript elongation (Lee et al., 2007; Xiao et al., 2005).ost & Microbe 11, 597–606, June 14, 2012 ª2012 Elsevier Inc. 597
Figure 1. Virus Infection and IFN Treatment Induce aGlobal Increase
in H2B-ub
(A) Western blot analysis of H2B and H2B-ub, E1A, and actin proteins
extracted from HAdV-infected A549 cells over a 48 hr time course.
(B) UV-inactivated HAdV and myxoma viruses and IFN treatment stimulate
a global increase in H2B-ub. A549 cells were infected with the indicated
viruses or treated with IFNb1. Cell extracts were analyzed as in (A) and also
blotted for GFP to demonstrate successful Myxoma infection.
(C) E1A expression is sufficient to block an IFN-induced global increase in
H2B-ub. Parental A549 and A549 cells stably expressing E1A were treated
with IFNb1 over 48 hr. Cells extracts were analyzed as in (A). See also
Figure S1.
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E1A Binds hBre1 to Block the Interferon ResponseH2B-ub is a precursor to several other epigenetic marks of
transcriptional activation, including trimethylation of histone 3
at lysines 4 (H3-K4) and 79 (H3-K79) by the COMPASS and
DOT1 complexes (Lee et al., 2007). H2B-ub is also required for
the displacement of H2B from the nucleosome by the FACT
complex (Xiao et al., 2005). This is thought to loosen the
surrounding DNA and allow for efficient passage of the RNA
polymerase II complex during transcript elongation. These
effects on transcription make regulation of the H2B-ub hPTM
a candidate target for a strong viral transcriptional regulator
such as E1A.
RESULTS
Cellular Levels of H2B-ub Greatly Increase in Response
to Viral Infection
To assess the effects of HAdV infection on global H2B-ub levels,
we infected human A549 lung adenocarcinoma cells with either
wild-type HAdV type 5 (WT) expressing the full-length E1A
protein or a virus lacking E1A (DE1A) and collected cells over
the following 48 hr (Figure 1A). HAdV DE1A is severely impaired
in the ability to reprogram the gene expression profile of the in-
fected cell (Ferrari et al., 2008) and would not be expected to
actively affect global histonemodifications. Unexpectedly, infec-
tion with HAdV DE1A stimulated a strong global increase in
H2B-ub by 8 hr postinfection that was sustained over the course
of our analysis. This suggests that cells responded to the pres-
ence of DE1A virus by globally increasing H2B-ub levels.
However, this increase was largely abrogated during infection
with the wild-type virus, which expresses E1A (Figure 1A). This
was also observed during infection of murine embryonic fibro-
blasts and the human diploid lung fibroblast line WI-38 (see
Figures S1A and S1D available online). These results suggested
that HAdV utilizes E1A to actively block the cellular upregulation
of the H2B-ub modification that occurs in response to virus
infection. Global H2B-ub was also stimulated upon infection by
UV inactivated wild-type HAdV (WT UVK) or the rabbit-specific
poxvirus, Myxoma virus (Myxoma UVK) (Figure 1B). H2B-ub
was reduced or blocked completely when cells were treated
with native viruses (Figure 1B). Interestingly, despite represent-
ing different virus families, both HAdV and Myxoma appear to
have evolved strategies that antagonize this cellular antiviral
response to virus exposure. Thus, the observed global H2B-ub
increase in response to virus infection likely results from a cellular
innate immune response to virus particles, rather than from the
activity of a viral protein.
Cellular Levels of H2B-ub Are Greatly Increased by Type
I IFN Treatment
Production of type I interferon (IFN) from virus-infected cells is
the hallmark characteristic of innate antiviral immunity. Type I
IFN exposure alters the expression of numerous cellular inter-
feron-stimulated genes (ISGs) (Der et al., 1998; Takaoka and
Yanai, 2006), rendering the cell more resistant to viral infection
(Sadler and Williams, 2008). We reasoned that the robust activa-
tion of over 300 cellular genes by type I IFN could be responsible
for the observed global upregulation of H2B-ub levels in
response to virus. When tested directly, treatment of A549 cells
with the interferon b1 (IFNb1) cytokine stimulated a strong global598 Cell Host & Microbe 11, 597–606, June 14, 2012 ª2012 Elsevierincrease in H2B-ub levels similar to that induced by infection with
defective viruses (Figure 1B). In addition, neither treatment with
IFN nor infection with HAdV DE1A increased H2B-ub levels in
Vero cells, which are unable to produce IFNb1 in response
to viral infection (Figure S1A). These data connect type I
IFN-induced antiviral immunity with a localized change in the
H2B-ub histone modification.
E1A Residues 4–25 Are Necessary to Block H2B-ub and
ISG Upregulation by Type I IFN
Transcription of ISGs has long been known to be induced
by HAdV particles, and E1A is known to block this type I IFN-
mediated response, although the exact mechanisms have notInc.
Figure 2. Infection Upregulates Global H2B-ub and ISG Transcrip-
tion in an hBre1-Dependent Manner, and This Is Blocked by HAdV
E1A via Residues 4–25
(A) A549 cells were infected with HAdV expressing wild-type E1A (WT) or the
indicated E1A deletion mutants in the presence or absence of IFNb1. Western
blot analysis was performed as in Figure 1A.
(B) A549 cells were infected with a panel of HAdV viruses alone or cotreated
with IFNb1 for 16 hr, and RNAwas extracted. Data were normalized to GAPDH
and set to fold increase over the uninfected control. A statistically significant
decrease in the transcription of all tested ISGs was found inWTHAdV-infected
as well as HAdV E1A D26–35 and HAdV E1A D30–49 infected cells as
compared to HAdV DE1A and HAdV D4–25 infected cells (p < 0.001). No
significant difference was detected virus alone or treated with IFNb1.
(C) A549 cells were treated with control siRNA or siRNA specific for hBre1
and infected with WT HAdV, HAdV DE1A, or IFNb1, and RNA was extracted.
RT-qPCR was performed with a panel of ISGs and normalized to GAPDH,
and fold change to uninfected ctrl siRNA-treated cells was plotted. Control
siRNA-treated HAdV DE1A and IFNb1 treated cells were found to be
statistically significant from all other groups, while all hBre1 siRNA-treated
groups were not found to be statistically upregulated as compared to unin-
fected control-treated cells (p < 0.001). Error bars represent ± SD. See also
Figure S3.
Cell Host & Microbe
E1A Binds hBre1 to Block the Interferon Responsebeen elucidated (Anderson and Fennie, 1987; Kalvakolanu et al.,
1991; Reich et al., 1988). We confirmed that E1A alone is neces-
sary and sufficient to block the IFNb1-induced global increase in
H2B-ub in A549 cells by producing an A549 line that stably
expresses E1A (Figure 1C).
To map the region of E1A required for blocking the type I IFN-
induced global increase in H2B-ub levels, we infected cells with
a panel of viruses containing deletions within the E1A protein in
the presence or absence of IFNb1 (Figure 2A, Figure S2A). A
virus lacking residues 4–25 of E1A behaved similarly to the
DE1A virus and triggered a global increase in H2B-ub. Deletions
in adjacent regions (D26–35 and D30-49) functioned in a manner
similar to WT E1A expressing virus, as infection with these
viruses did not induce H2B-ub. Thus, the N-terminal region of
E1A is essential for inhibition of H2B-ub induction. Identical
results were seen in the presence or absence of IFNb1, demon-
strating that E1A effectively abrogates the induction of H2B-ub
whether it is indirectly induced by cellular recognition of the virus
particle or directly by exposure to IFNb1. We also compared the
transcriptional effects of virus infection and type I IFN treatment
on a representative subset of well-established ISGs (Figure 2B)
and a panel of control genes not known to be IFN responsive
(Figures S3B–S3E). As expected, IFNb1 treatment strongly
induced expression of all six ISGs, but not the control genes.
The effect of virus infection on ISG expression, but not the
control genes, closely mirrored the effects seen on global
H2B-ub levels during virus treatment. Specifically, infection
with HAdV DE1A or the D4–25 virus caused a robust increase
in ISG transcriptional activation similar to that caused by IFNb1
treatment. However, WT HAdV, as well as viruses with deletions
in E1A adjacent to 4–25, largely blocked activation of ISG
expression. These data establish a strong correlation between
the ability of E1A to block IFN-dependent transcription and the
ability to block global increases in H2B-ub levels.
The Early Stages of the Type I IFN Response Are Not
Blocked by E1A
During infection with WT HAdV, IRF3 became phosphorylated
and was recruited to the IFNb1 promoter (Figures S1B and
S1C). Thus, the earliest stages of the type I IFN response
induced by infection remain intact. However, the global increase
in H2B-ub induced by E1A mutant HAdV was not detected in
MEFs deficient for both the type I IFN receptors (IFNa/bR/)
and MEFs lacking IRF3 (IRF3/) (Figure S1D). This confirmed
that the increase in H2B-ub expression, observed upon infection
with HAdV-expressing mutant E1A, was dependent on the IFN
response. Given that NFkB is a key regulator of inflammation,
we determined if the region of E1A necessary to repress NFkB
activity is the same as that required to repress ISG transcription.
We compared the ability of the panel of E1A mutant viruses to
affect NFkB response.WhileWTE1A could repress NFkBactiva-
tion, all of the N-terminal E1A mutants have lost this ability
(Figure S1E). As several E1A mutants are unable to repress
NFkB-dependent transcription but are still able to block type I
IFN responses, this activity may be of secondary importance
for viral evasion of the innate immune response. As the viral E4
region encodes E4 orf3, which is known to antagonize the IFN-
induced antiviral state (Ullman et al., 2007), we examined
whether the effects of E1A could also be mediated via activationCell Host & Microbe 11, 597–606, June 14, 2012 ª2012 Elsevier Inc. 599
Figure 3. E1A Binds hBre1 through Residues 4–25, and This Blocks
hBre1 Association with Ube2b
(A) A549 cells were infected with wild-type HAdV or HAdV expressing the
indicated E1A deletion mutants for 16 hr at an moi of 5. E1A was immuno-
precipitated, and western blots were performed using antibodies specific to
the indicated hBre1 complex components.
(B) HT1080 cells were transfected with E1A or an E1A deletion mutant as well
as tagged hBre1 and tagged Ube2b. Coimmunoprecipitation was performed
by IP with an antibody specific to tagged Ube2b. Western blot analysis was
performed with an antibody specific to the tagged hBre1. See also Figure S5.
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E1A Binds hBre1 to Block the Interferon Responseof viral E4 expression. As reported (Nevins, 1981), E1A does
activate E4 expression. However, an E1A mutant (D30–49)
unable to activate E4 orf3 expression was still able to block
type I IFN responses (Figure 2B, Figure S1F). This indicates
that E4-mediated effects are not necessary for the inhibition of
ISG expression, and this agrees with our observation that E1A
expression alone was necessary and sufficient to block IFNb1
effects (Figure 1C).
hBre1 Is Necessary for IFN-Induced Gene Transcription
Human Bre1/RNF20 (hBre1) is the E3 ubiquitin ligase which acts
in conjunction with the E2 ubiquitin conjugase Ube2b, and
accessory factors RNF40 and WAC, to monoubiquitinate H2B
at lysine 120 (Hwang et al., 2003; Kim et al., 2009; Zhang and
Yu, 2011). While H2B-ub is a hPTM that is generally associated
with transcriptional activation, hBre1 depletion only affects the
expression of a small subset of genes (Shema et al., 2008).
However, the involvement of hBre1 in IFN-induced activation of
ISG transcription has never been assessed. A549 cells were
treated with either a nonspecific control siRNA or an siRNA
specific for hBre1, and then exposed to WT HAdV, HAdV DE1A,
or IFNb1. The expression level of six ISGs (Figure 2C) and a panel
of control genes not responsive to IFNb1 (Figures S3B–S3E) was
determined. As expected, IFNb1 and HAdV DE1A induced high
levels of ISG transcriptional activation in cells treated with
a nonspecific control siRNA, whereas wild-type HAdV did not
strongly stimulate ISGs (Figure 2C). In contrast, knockdown of
hBre1 with specific siRNA blocked ISG transcriptional activation
under any treatment condition (Figure 2C). Similar results were
obtained with siRNA against RNF40 (Figure S3A). These data
provide evidence that the hBre1 complex is an essential compo-
nent of the IFN-stimulated antiviral response and link transcrip-
tional activation of ISGsand the ensuing innate immune response
with hPTM changes in H2B-ub status. These effects appear
specific, as expression of the non-IFN-responsive genes was
not decreased by knockdown of hBre1 or RNF40 (Figure S3B).
Furthermore, knockdown of either hBre1 or RNF40 had no effect
on apanel of non-ISGs known to be affected byE1A (Figures S3C
and S3D), and little if any H2B-ub could be detected on these
genes by chromatin immunoprecipitation (ChIP) assays (Fig-
ure S4). We also examined the effect of E1A on three genes re-
ported to be regulated by hBre1 (HoxA10, fosL2, and p53).
Although expression of each of these genes was reduced upon
knockdown of hBre1 or RNF40 (Figure S3F) and had detectable
levels of H2B-ub (Figure S4), their expression was not blocked
by E1A (Figure S3E). Thus, the effects of E1A on hBre1 may not
affect genes with H2B-ub that exists prior to infection, or they
may be restricted in some other fashion to ISGs. This may be
related to the observation that recruitment of E1A to cellular
promoters varies temporally, such that several distinct classes
of promoters have been defined based on the kinetics of E1A
occupancy (Ferrari et al., 2008).
The hBre1 Complex Is Disrupted by E1A
E1A is an intrinsically disordered protein that functions by
binding to cellular proteins and affecting their normal functions
(Ferreon et al., 2009; Pelka et al., 2008). We therefore tested
the ability of E1A to physically interact with members of the
hBre1 complex, which includes hBre1, RNF40, and Ube2b. To600 Cell Host & Microbe 11, 597–606, June 14, 2012 ª2012 Elsevierdo this, we infected A549 cells with HAdVs expressing either
WT or deletion mutant E1A proteins. Lysates from infected cells
were immunoprecipitated using an E1A-specific antibody, and
the presence of hBRE1, RNF40, and Ube2b was assayed by
immunoblotting using antibodies specific to these proteins (Fig-
ure 3A). Both hBre1 and RNF40, but not Ube2b, coprecipitated
with E1A. Furthermore, the association of E1A with hBre1 and
RNF40 required E1A residues 4–25 (Figure 3A), the same resi-
dues which are required to block global increases in H2B-ub
levels and IFN-induced ISG transcription (Figures 2A and 2B).
The interaction between E1A and hBre1 was further confirmed
by coimmunoprecipitation of E1A with endogenous hBre1
(Figure S5A) or transfected epitope tagged hBre1 or RNF40
(Figure S5B). However, E1A did not coimmunoprecipitate with
epitope-tagged Ube2b (Figure S5B).Inc.
Figure 4. The The H2B-ub hPTM Is Present at ISGs upon IFN Induc-
tion, and This Is Blocked by E1A
The identity of each gene tested is indicated at the top of each figure. A549
cells were infected withWT HAdV,DE1A HAdV, or E1AD4–25 HAdV or treated
with IFNb1 for 16 hr. Chromatin immunoprecipitation (ChIP) was then per-
formed. Chromatin was analyzed for the presence of the following proteins
with specific antibodies: nonspecific control, H2B, and H2B-ub. DNA was
then quantitated via qRT-PCR using the indicated gene-specific primers.
Data significantly different than uninfected control within groups are indicated
(*p < 0.001). Error bars represent ± SD. See also Figure S6.
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E1A Binds hBre1 to Block the Interferon ResponseThe inability of E1A to interact with Ube2b suggested that E1A
interfered with the association between hBre1 and the Ube2b
catalytic subunit. Perturbation of the interaction between the
hBre1/RNF40 E3 ligase with the E2 conjugase Ube2b provides
an attractive mechanism by which E1A could block type I IFN-
induced H2B-ub and antiviral gene expression. To test this
directly, we transfected tagged hBre1 and Ube2b along with
wild-type E1A or E1A mutants into HT1080 cells. As expected,
hBre1 was readily coimmunoprecipitated with Ube2b (Kim
et al., 2009) in the absence of E1A (Figure 3B). However, this
interaction was disrupted in the presence of E1A, and this,
once again, required residues 4–25 of E1A (Figure 3B). Thus,
the identical region of E1A (residues 4–25) that is required to
abrogate type I IFN induction of H2B-ub levels and ISG expres-
sion (Figures 2A and 2B) was also required for the association
with and disruption of the hBre1 complex (Figure 3B). Serial
immunoprecipitation of endogenous E1A from HEK293 cells
showed that a substantial amount of hBre1 was not coimmuno-
precipated with E1A. This suggested that E1A interacted with
only a small, and perhaps distinct, subset of the total cellular
hBre1 pool (Figure S5C). These data support a model whereby
the interaction of E1Awith the hBre1 complex specifically blocks
H2B-ub, which is required for gene expression, by excluding
the catalytic Ube2b ubiquitin conjugase subunit from the hBre1
complex.
hBre1 and Ube2b Are Recruited to ISGs during Innate
Immune Stimulation
H2B-ub is considered to be a hPTM that is preferentially associ-
ated with chromatin that is transcribed at high levels (Batta et al.,
2011; Shema et al., 2008). Given the requirement of hBre1 for
type I IFN-induced gene expression, we predicted that H2B-ub
would be present in the transcribed chromatin of actively ex-
pressed ISGs. Indeed, ChIP assays determined that H2B-ub
was present within the transcribed regions, as well as the
promoter regions, of a panel of ISGs upon infection with HAdV
DE1A or treatment with IFNb1 (Figures 4 and 5). Furthermore,
this chromatin modification was not present during wild-type
HAdV infection (Figures 4 and 5), suggesting that expression of
E1A was locally inhibiting this histone modification as a mecha-
nism to block type I IFN-induced antiviral gene expression.
Unlike wild-type virus, infection with HAdV E1A D4–25 induced
H2B-ub in the transcribed regions of ISGs (Figure 4), further
indicating that this region was essential for antagonizing IFN-
induced H2B-ub. ChIP analysis also demonstrated strongly
increased hBre1 occupancy of the ISGs in response to infection
with WT HAdV or HAdV DE1A or treatment with IFNb1. This
occurred regardless of the presence or absence of E1A (Fig-
ure S6A). This suggested that E1A does not interfere with recruit-
ment of hBre1 to the target chromatin. Indeed, hBre1 and E1A
were found to colocalize to ISGs during innate immune stimula-
tion by ChIP-reChIP experiments (Figure S6B). Furthermore, E1A
was localized to the transcribed regions of ISGs duringWTHAdV
infection and could potentially be recruited via its interaction with
hBre1. Ube2b was found to localize with hBre1 within the tran-
scribed region of ISGs after IFN treatment or exposure to
HAdV DE1A (Figures S6A and S6C). In contrast to hBre1, the
Ube2b ubiquitin conjugase was absent in the presence of wild-
type E1A (Figure S6A). H2B-ub or hBre1 was not found withinCell Hthe transcribed regions of genes regulated by E1A but not IFN
(Figure S4). Taken together, these data support amodel whereby
IFN treatment stimulates the localized formation of an enzymat-
ically competent hBre1 complex and subsequent H2B-ub
modification of the chromatin of IFN-regulated genes. E1A
antagonized this process by displacing Ube2b from the hBre1
complex (Figure 7). Furthermore, H3-K4 and H3-K79 trimethyla-
tion in the promoter regions of ISGs was blocked under condi-
tions in which H2B-ub was antagonized by E1A (Figure 5). This
was expected, as these hPTMs are marks of transcriptional
activation that require H2B-ub (Kim et al., 2009; Mohan et al.,
2010). This was not the case with H3 acetylation (H3ac) status,
which has not been shown to depend on H2B-ub (Figure 5).ost & Microbe 11, 597–606, June 14, 2012 ª2012 Elsevier Inc. 601
Figure 5. hPTMs Related to H2B-ub Are
Similarly Induced by IFN and Reduced
by E1A
Cells treated as in Figure 4, and were chromatin
immunoprecipitated with a nonspecific control
antibody or antibodies recognizing H2B, or the
indicated hPTMs. qRT-PCR was performed using
primers specific to the promoter region. Data
significantly different than uninfected control within
groups are indicated (*p < 0.001). Error bars
represent ± SD. See also Figure S4.
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E1A Binds hBre1 to Block the Interferon ResponseSpecifically, changes in H3K18 acetylation of ISG promoters,
which is another mark altered by E1A during infection, did not
consistently correlate with transcriptional activation of ISGs or
H2B-ub status (Figure S6D).
hBre1 Is Required for Activation of the Type I IFN-
Mediated Innate Immune Response against Virus
Infection
To establish the biological significance of the interaction of E1A
with the hBre1 complex, we assessed the effect of type I IFN on
virus replication. A549 cells were treated with siRNA specific to
hBre1, RNF40, or both hBre1 and RNF40 prior to infection in602 Cell Host & Microbe 11, 597–606, June 14, 2012 ª2012 Elsevier Inc.the presence or absence of IFNb1.
Production of infectious viral progeny
was assayed at various time points over
48 hr (Figure 6, Figure S7). WT virus was
unaffected by IFNb1 treatment, by knock-
down of hBre1, or by RNF40 alone or in
combination. In stark contrast, growth
of virus expressing E1A D4–25 was
completely abrogated by IFNb1 treatment
(Figure 6, Figure S7). Importantly, knock-
down of hBre1 or RNF40 alone or in
combination by siRNA relieved the hyper-
sensitivity of the E1A D4–25 virus to IFN,
allowing substantial virus replication in
the presence of IFNb1 (Figure 6, Fig-
ure S7). Thus, the inability of this mutant
to interact with the hBre1 complex greatly
sensitized this virus to the IFNb-mediated
innate immune response. These data
confirm the importance of the hBre1
complex in establishing the IFN mediated
antiviral state.
DISCUSSION
This study has identified a previously
unsuspected requirement for the hBre1
complex and its ability to enzymatically
modify chromatin in the type I IFN re-
sponse (Figure 7). hBre1 functions as
a ubiquitin ligase in conjunction with the
ubiquitin conjugase Ube2b and acces-
sory factors RNF40 andWAC tomonoubi-
quitinate H2B at lysine 120 (Hwang et al.,2003; Kim et al., 2009; Zhang and Yu, 2011). H2B-ub marks
chromatin that is highly transcriptionally active, is involved in effi-
cient transcript elongation (Lee et al., 2007; Xiao et al., 2005), and
is a precursor to several other epigenetic marks of transcriptional
activation including trimethylation of H3-K4 and H3-K79 (Lee
et al., 2007).
hBre1 depletion only affects the expression of a small subset
of genes (Shema et al., 2008), suggesting that it serves a regula-
tory role that may be restricted for specific purposes. Studies in
yeast similarly support the concept that the H2B-ub hPTM is not
necessary for the general control of transcription, as yeast
unable to monoubiquinate H2B do not have obvious global
Figure 6. Growth of a Mutant Adenovirus Unable to Bind the hBre1 Complex Is Abrogated by Type I IFN Treatment, and hBre1 or RNF40
Knockdown Complements This Replication Defect
A549 cells were treatedwith control siRNA or siRNA specific to hBre1, RNF40, or both in combination prior to infection withWT virus (moi of 5) or HAdV E1AD4–25
(moi of 20). Infected cells were treated with or without IFNb1. Cells were collected at various time points up to 48 hr postinfection to prepare virus lysates.
Production of infectious progeny virus was quantitatively assayed by plaque formation on HEK293 cells. Data are shown over 24–48 hr. Growth of WT HAdV is
unaffected by IFNb1 treatment, whereas growth of HAdV E1A D4–25, which is unable to target the hBre1 complex, is abrogated by IFNb1 treatment. Knockdown
of hBre1 or RNF40 partially restores growth of HAdV E1A D4–25 in the presence of IFNb1. See also Figure S7.
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E1A Binds hBre1 to Block the Interferon Responsedefects (Hwang et al., 2003). We directly confirmed that the
hBre1 complex was required for the cellular IFN response by
knocking down the hBre1 ubiquitin ligase or the accessory factor
RNF40 (Figure 2C, Figure S3A). Specific knockdown of either
factor using siRNA greatly reduced ISG expression that is
directly induced in response to treatment with IFNb1 or indirectly
induced by infection with attenuated virus. In contrast, targeted
knockdown did not alter the expression of a panel of genes not
known to be regulated by IFN (Figures S3B–S3D). Furthermore,
we detected each of the hBre1, RNF40, and Ube2b components
of the hBre1 complex co-occupying the coding regions of ISGs
in response to activation of IFN signaling (Figures S6A and
S6C). These results directly demonstrate that the hBre1 complex
is necessary for the IFN-induced program of gene expression
and further confirm that the activity of hBre1 is confined to
specific transcriptional programs. Our discovery that hBre1 is
required for the transcriptional program induced by type I IFN
adds substantially to the short list of pathways for which H2B-
ub is an epigenetic modification required for expression. To
date, this has included HOX, Notch, estrogen receptor, and
p53 responses (Bray et al., 2005; Mohan et al., 2010; Moyal
et al., 2011; Nakamura et al., 2011; Prenzel et al., 2011; Shema
et al., 2008; Zhu et al., 2005). Like the type I IFN response, in
each of these cases rapid and substantial increases in the
transcription of target genes occur.
Interestingly, a global increase in H2B-ub was not observed
during infection with HAdV-expressing E1A or when cells stably
expressing E1A were exposed to IFNb1. Thus, the viral E1A
protein is necessary and sufficient to overcome this IFNb1-Cell Hdependent global upregulation of the H2B-ub hPTM. Inhibition
of the global increase in H2B-ub stimulated either by adenovirus
infection or IFNb1 treatment specifically required HAdV E1A resi-
dues 4–25 (Figure 2A). E1A residues 4–25 were also required to
block transcriptional activation of ISGs (Figure 2B). However,
adjacent regions of E1A necessary for binding other chromatin
modifiers were not required to inhibit H2B-ub upregulation and
ISG transcription (summarized in Figure S2B). This excludes indi-
rect effects of E1A mediated by its interaction with general and
ubiquitous coregulators of transcription. We reasoned that E1A
may instead function via direct interference with the cellular
apparatus responsible for creating the H2B-ub hPTM.
We identified a physical interaction between E1A and the
hBre1 complex, which required the exact same region of E1A
necessary for blocking H2B-ub upregulation and ISG transcrip-
tion (Figure 3A). In addition, the interaction of E1A with hBre1
blocked its association with Ube2b, the catalytic component of
the complex involved in monoubiquitination of H2B (Figure 3B),
and prevented the association of Ube2bwith ISG-coding regions
in response to IFN signaling (Figure S6A). This provides an
elegant mechanism by which E1A inhibits H2B-ub and subse-
quent epigenetic marks dependent on this modification at ISGs
(Figure 7), including H3-K4 and K79 trimethylation (Figure 5).
Similarly to what we have observed with H2B-ub, E1A globally
alters H3-K18 acetylation by targeting several cellular histone
acetyltransferases to alter cell growth (Ferrari et al., 2008).
Clearly the versatile E1A protein has evolved to exploit interac-
tionswith cellular chromatin-modifying enzymesas amechanism
to efficiently reprogram transcription in the infected cell.ost & Microbe 11, 597–606, June 14, 2012 ª2012 Elsevier Inc. 603
Figure 7. The hBre1 Complex Is Involved in the Transcription of
Interferon-Stimulated Genes, and E1A Blocks This Process by Dis-
rupting the Interaction between hBre1 and Ube2b
Exposure to type I IFN or the innate immune response to virus infection results
in the recruitment of the hBre1 complex to the transcribed regions of ISGs.
Here, the catalytically active hBre1 complex monoubiquitinates H2B at K120,
resulting in the efficient transcription of ISGs. To counteract this innate immune
defense during virus infection, HAdV produces the E1A protein, which binds to
hBre1, inhibiting the binding of Ube2b to the hBre1 complex. This results in
a loss of Ube2b occupancy at the ISG, a loss of monoubiquitination of H2B
within the chromatin of ISGs, and a subsequent lack of ISG transcription.
Blockade of this hPTM by the viral E1A protein abrogates the large-scale
changes in cellular gene expression induced by the IFN innate immune
response. See also Figure S2.
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ments, and it is known that this virus encodes multiple proteins
that counteract the activities of specific IFN-induced antiviral
pathways (Thimmappaya et al., 1982; Weitzman and Ornelles,
2005). Each of these known viral countermeasures is produced
later in infection than E1A. As E1A is the first protein expressed
during an HAdV infection, it likely represents the first line of
defense against the IFN response. In order to establish if the
interaction of E1A with hBre1 contributes to evading the type I
IFN response, we tested the effects of IFN on growth of WT
HAdV and a mutant lacking residues 4–25 of E1A. As expected,
IFN treatment had no effect on growth ofWT HAdV. Although the
mutant virus lacking residues 4–25 of E1A grewmore poorly than
WT virus, its growth was completely abrogated by IFN treatment
(Figure 6, Figure S7). These growth characteristics confirm that
a virus lacking the ability to bind hBre1 and interfere with
H2B-ub is hypersensitive to IFN. Importantly, knockdown of
hBre1, RNF40, or both hBre1 and RNF40 simultaneously prior
to HAdV infection partially restored growth of the D4–25 virus
in the presence of IFN (Figure 6, Figure S7). Thus, knockdown
of the hBre1 complex genetically complements the inability of
this mutant virus to target hBre1 and abrogate the IFN response.
Furthermore, these experiments confirm the biological signifi-
cance of the hBre1 complex in the IFN mediated antiviral
response.
It was recently reported that the NS1 protein of influenza H3N2
contributes to suppression of the innate immune response by
targeting the PAF1 transcriptional elongation complex (Marazzi
et al., 2012). Although the PAF1 complex does not contain any604 Cell Host & Microbe 11, 597–606, June 14, 2012 ª2012 Elsevierenzymatic activities that directly modify chromatin, it plays
a role in recruiting the hBre1 complex to enhance H2B-ub, tran-
scriptional elongation, and H3-K4 methylation (Kim et al., 2009).
Although the effect of influenza NS1 on H2B-ub is not currently
known, its interference with PAF1 function will likely reduce
H2B-ub, similarly to what we observed with E1A. Thus, adenovi-
ruses, influenza A, and potentially other viruses have indepen-
dently evolved mechanisms to interfere with the innate immune
response by antagonizing hPTMs required for ISGs expression.
This convergence of function highlights the importance of chro-
matin modification in the regulation of the type I IFN response.
hBre1 has also been suggested to function as a tumor-
suppressor gene (Blank et al., 2012; Kim et al., 2009; Moyal
et al., 2011). This is intriguing, as the type I IFN response is
important in resisting cancer, as well as in controlling infection.
Indeed, many cancers lose the ability to respond to IFN
(Domschke et al., 2009; Hirsch et al., 2010; Krishnamurthy
et al., 2006; Marozin et al., 2008), and the importance of immune
evasion has been formally acknowledged by inclusion in the
recently revised list of the hallmarks of cancer (Hanahan and
Weinberg, 2011). Our data demonstrating that loss of hBre1
function confers a loss of IFN responsiveness may provide
some mechanistic insight into its putative role as a tumor
suppressor (Shema et al., 2008).
In summary, our studies of E1A have uncovered an
essential role for the hBre1 complex in the type I IFN response,
which is summarized in Figure 7. The type I IFN-induced tran-
scriptional program is comprised of >300 ISGs, and the estab-
lishment of this antiviral state is accompanied by a local increase
in H2B-ub at each ISG that collectively leads to a readily detect-
able global increase in H2B-ub. Mechanistically, we show that
this hPTM requires the recruitment of the hBre1 complex to
ISGs, resulting in additional hPTM modifications and culminat-
ing in efficient IFN-induced gene expression. We also identify
a unique and elegant mechanism by which a viral oncoprotein
subverts the type I IFN-mediated cellular antiviral response by
specifically antagonizing this hPTM. This work also exemplifies
how studying interactions between viruses and their hosts
can provide mechanistic insight into fundamental biological
processes.EXPERIMENTAL PROCEDURES
Cell Lines and Plasmids
Human adenocarcinoma A549 and human fibrosarcoma HT1080 cells were
grown at 37C, 5%CO2 in DMEM (Multicell) and supplemented with 10% fetal
bovine serum (GIBCO). Plasmids were transfected into HT1080 cells using
Superfect reagent (QIAGEN) following the manufacturer’s recommendations.
Transfection efficiency was typically 60%–70%. After 24 hr in culture, trans-
fected cells were used for experimentation. hBre1 and RNF40 were cloned
as a myc tag fusion into pCAN-myc. Ube2b was cloned as an HA tag fusion
into pcDNA4.
Quantitative RT-PCR
Total RNA was prepared with Trizol extraction (Invitrogen). A total of 1 mg of
RNA was reverse transcribed into cDNA by random priming using the One-
Step RT-PCR Kit (QIAGEN) following the manufacturers’ instructions. Quanti-
fication of cDNA was done using SYBR Green supermix for real-time qPCR
(MyIQ, Bio-Rad) with oligonucleotide sequences that specifically recognize
GAPDH, IFITM1, IFNb1, IRF9, Mx1, OAS1, and OAS2. GAPDH was used as
a control for total cDNA. Controls without reverse transcriptase were doneInc.
Cell Host & Microbe
E1A Binds hBre1 to Block the Interferon Responsefor each RNA sample alongside the cDNA control. Results were normalized to
the GAPDH and uninfected sample. The oligonucleotide sequences are listed
in Table S1.
RNAi Knockdown
Downregulation of hBre1 and RNF40 was performed using Silencer Select
siRNA (Ambion). siRNA was delivered to cells via transfection with Silentfect
(Bio-Rad) following the manufacturer’s instructions, 3 hr after seeding cells,
for a period of 48 hr. A scrambled siRNA was used as a control.
Virus and Type I Interferon Treatment of Cells
Cells were infected with human adenovirus (HAdV5) wild-type (dl309), or
a panel of HAdV containing the indicated E1A deletion mutations: DE1A
(dl312), E1A D4–25 (dl1101), E1A D26–35 (dl1102), and E1A D30–49 (dl1103).
HAdV was used at a multiplicity of infection (moi) of 5 pfu/cell. Myxoma was
used at an moi of 20. Cell cultures were infected at 50% confluence and left
for 16 hr. Virus infection was found to be near 100% by fluorescence micros-
copy under these conditions using virus expressing GFP. Interferon b1 (IFNb1)
(Cedarlane 11420-1) was added at 1 unit/mL to the cell media for 16 hr. In
cotreatment experiments, cells were first infected with HAdV at an moi of
5 for 4 hr before the addition of 1 unit/mL of IFNb1 for an additional 14 hr.
Subconfluent cells were collected for further experimentation.
Acid Extraction of Histones
4 3 105 cells were collected after treatment and lysed with NP40 lysis buffer
(0.5% NP-40, 150 mM NaCl, 50 mM Tris [pH 7.8]). Cells were pelleted, and
pellets were then treated overnight with 0.1 M HCl. Protein concentrations
were then determined using the Bio-Rad protein assay reagent, using BSA
as a control after neutralizing the HCl.
Western Blotting and Coimmunoprecipitation
Cells were lysed with NP40 lysis buffer and protein concentrations were deter-
mined with Bio-Rad protein assay reagent using BSA as a standard. Protein
lysate (0.5 mg) was immunoprecipitated with myc or HA hybridoma superna-
tant or 6 mg of anti-mouse IgG (Sigma M-7023) at 4C for 4 hr. Protein (25 mg)
was kept as 5% input, except as noted in the figure legend of individual blots.
After three washes in NP40 lysis buffer, complexes were boiled in 25 ml of
sample buffer for 5 min. Proteins were separated on NuPage 4%–12% Bis-
Tris gradient gels (Invitrogen) and transferred onto a nitrocellulose membrane
(Amersham). Membranes were blocked in TBS with 0.1% Tween-20 and 5%
skim milk or BSA and blotted with the indicated primary overnight at 4C.
Details for the primary antibodies may be found in Table S2. Horseradish
peroxidase-conjugated secondary antibodies were detected using ECL plus
western blotting detection system (Amersham).
Chromatin Immunoprecipitation and ChIP-reChIP
Approximately 107 cells per sample were crosslinkedwith 1% formaldehyde at
room temperature for 10 min. Cells were washed twice with ice-cold PBS and
harvested. Cell pellets were lysed in 1 mL of cell lysis buffer (50 mM Tris-HCl
[pH 8.1], 10 mM EDTA, 1% SDS) and a protease inhibitor cocktail (Sigma)
on ice for 10 min. Lysates were sonicated in an ultrasonic biorupter bath
(Diogenode XL-2006 TO) to yield DNA fragment sizes of 200–500 base pairs.
Samples were then centrifuged at 10,000 3 g for 10 min. Protein (1 mg) was
used for ChIP; 100 mg of this was kept as 5% input. Supernatants were then
diluted 10-fold in dilution buffer (20 mM Tris-HCl [pH 8.1], 1% Triton X-100,
2 mM EDTA, 150 mM NaCl, and protease inhibitors) and precleared with
50 ml of ChIP protein-A Sepharose (50% slurry of protein A Sepharose contain-
ing 2.5 mg of salmon sperm DNA and BSA/mL) for 50 min at 4C. Immunopre-
cipitations were performed overnight at 4C using 5 mg of the indicated
antibody found in Table S2. The next morning, 50 ml of ChIP protein A
Sepharose was incubated with each sample for 2 hr. Beads were then washed
once each with 500 ml of wash buffer 1 (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris-HCl [pH 8.1], 150 mM NaCl), wash buffer II (0.1% SDS,
1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl [pH 8.1], 500 mM NaCl), and
wash buffer III (0.25 M LiCl, 1% NP-40, 1% Na-deoxycholate, 1 mM EDTA,
10 mM Tris-HCl [pH 8.0]), respectively, and then washed twice with Tris-
EDTA buffer. Immunocomplexes were extracted twice with 150 ml of elution
buffer (1% SDS, 0.1 M NaHCO3). For ChIP-reChIP, samples were thenCell Hrediluted 103 with dilution buffer, and immunoprecipitation was repeated
with a second antibody as indicated. After final elution, 12 ml of 5M NaCl
was added to the 300 ml pooled elution and incubated at 65C overnight to de-
crosslink the complexes. DNAwas then purified using Qiagen PCR purification
spin columns. Conditions for qRT-PCR using SYBR Green were as per the
manufacturers’ directions. Briefly, each 15 ml reaction contained 80 nM oligos
and 0.5 uL of ChIP DNA.
Statistical Analysis
All numerical values represent means ± SEM. Each experiment was done in
three replicates, and a representative replicate is shown for each blot. Statis-
tical significance of the differences was calculated using one-way ANOVA and
Holm-Sidak post hoc test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
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